Dale Broadrick - 30 Nov 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Issuer symbol
BRTX
Transactions as of
30 Nov 2022
Net transactions value
+$17,705
Form type
4
Filing time
03 Mar 2023, 15:11:37 UTC
Previous filing
27 Sep 2022
Next filing
28 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $278 +100 +0.03% $2.78 298,973 30 Nov 2022 Direct
transaction BRTX Common Stock Purchase $277 +100 +0.03% $2.77 299,073 30 Nov 2022 Direct
transaction BRTX Common Stock Purchase $14,200 +5,000 +1.7% $2.84 304,073 22 Feb 2023 Direct
transaction BRTX Common Stock Purchase $2,950 +1,000 +0.33% $2.95 305,073 22 Feb 2023 Direct
holding BRTX Common Stock 316,972 30 Nov 2022 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 125 30 Nov 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 125 30 Nov 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 30 Nov 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 30 Nov 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 30 Nov 2022 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Owned by Fleetco, Inc. of which reporting person is a 93% shareholder.